Mr. Smith offers more than 20 years of financial, operational and strategic leadership experience, including as CFO of Translate Bio.
Prior to CRISPR Therapeutics, Mr. Smith was the Chief Financial Officer & Corporate Strategy of Translate Bio, a leading mRNA company that was recently acquired by Sanofi for $3.2B. Mr. Smith is an accomplished e...
Roles at CRISPR Therapeutics
October, 2021 - present
My work style
How I prefer to work
Qualities I value in my colleagues
Sign up to see more about the team at CRISPR Therapeutics
My pet peeves
My communication style